We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CEQP
2201
DELISTED
Crestwood Equity Partners LP
CEQP
$127K ﹤0.01%
4,474
+3,403
+318% +$94.5K
CCCC icon
2202
C4 Therapeutics
CCCC
$428M
$126K ﹤0.01%
2,824
+1,680
+147% +$71.9K
FORM icon
2203
FormFactor
FORM
$9.46B
$126K ﹤0.01%
3,371
+1,329
+65% +$49.5K
KRYS icon
2204
Krystal Biotech
KRYS
$9.68B
$126K ﹤0.01%
2,410
+558
+30% +$33K
CMA
2205
DELISTED
Comerica
CMA
$125K ﹤0.01%
1,545
-1,012
-40% -$72.8K
IHE icon
2206
iShares US Pharmaceuticals ETF
IHE
$1.65B
$125K ﹤0.01%
+2,055
New +$131K
ADAM
2207
Adamas Trust
ADAM
$919M
$125K ﹤0.01%
7,331
-3,350
-31% -$58.3K
PFBC icon
2208
Preferred Bank
PFBC
$1.26B
$125K ﹤0.01%
1,876
+735
+64% +$45K
SVC
2209
Service Properties Trust
SVC
$1.05B
$125K ﹤0.01%
2,239
-1,981
-47% -$113K
DARE icon
2210
Dare Bioscience
DARE
$21.6M
$124K ﹤0.01%
6,187
+6,099
+6,931% +$120K
FPX icon
2211
First Trust US Equity Opportunities ETF
FPX
$1.49B
$124K ﹤0.01%
+1,007
New +$128K
PLNT icon
2212
Planet Fitness
PLNT
$3.62B
$124K ﹤0.01%
1,577
-1,272
-45% -$96.7K
SAND
2213
DELISTED
Sandstorm Gold
SAND
$124K ﹤0.01%
21,652
+12,713
+142% +$87.8K
PRTK
2214
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$124K ﹤0.01%
25,536
-6,227
-20% -$34.3K
KAI icon
2215
Kadant
KAI
$4B
$123K ﹤0.01%
600
+3
+0.5% +$591
NUS icon
2216
Nu Skin
NUS
$236M
$123K ﹤0.01%
3,034
-13,095
-81% -$663K
RDHL
2217
Redhill Biopharma
RDHL
$3.65M
$123K ﹤0.01%
27
+24
+800% +$163K
ECHO
2218
EchoStar
ECHO
$25.6B
$123K ﹤0.01%
4,817
+302
+7% +$7.45K
TPOR icon
2219
Direxion Daily Transportation Bull 3X ETF
TPOR
$20.9M
$123K ﹤0.01%
+3,648
New +$139K
UCTT
2220
Ultra Clean Holdings
UCTT
$3.9B
$123K ﹤0.01%
2,904
-4,260
-59% -$201K
URBN icon
2221
Urban Outfitters
URBN
$6.8B
$123K ﹤0.01%
4,155
-10,158
-71% -$363K
BCOV
2222
DELISTED
Brightcove, Inc.
BCOV
$123K ﹤0.01%
10,691
+8,731
+445% +$106K
CURO
2223
DELISTED
CURO Group Holdings Corp.
CURO
$123K ﹤0.01%
7,140
-12,194
-63% -$201K
HYFM icon
2224
Hydrofarm Holdings
HYFM
$7.96M
$122K ﹤0.01%
322
+250
+347% +$121K
ATRS
2225
DELISTED
Antares Pharma, Inc.
ATRS
$122K ﹤0.01%
33,695
+27,972
+489% +$113K
87 88
89
90 91

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.